Sodium polystyrene sulfonate 15000 MG Powder for Oral Suspension — RxCUI 2101899
RxNorm drug concept · Semantic clinical drug
RxCUI 2101899
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
20 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2101899
Official nameSodium polystyrene sulfonate 15000 MG Powder for Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assodium polystyrene sulfonate 15 to 60 GM Powder for Oral Suspension; sodium polystyrene sulfonate 15 GM Powder for Suspension; sodium polystyrene sulfonate 30 to 50 GM Powder for Rectal Suspension; sodium polystyrene sulfonate 4.1 MEQ in 1 GM Powder for Oral Suspension
FDA products mapped12
Package NDCs mapped20
Reported Medicaid activity (SDUD)5,081 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sodium Polystyrene Sulfonate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Think of it like a sponge that travels through your gut. It swaps out sodium for potassium along the way, grabbing extra potassium and carrying it out of your body in your stool. Y...
- What exactly is this medicine doing to my body?
- That's one of the most important things to understand about this medicine — it's slow. It can take anywhere from several hours to a couple of days to meaningfully lower your potass...
- No — and this is really important. This resin can grab on to other medications in your stomach and prevent them from being absorbed properly. You need to take all your other oral m...
🕸️ Concept Web — How Sodium polystyrene sulfonate 15000 MG Powder for... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sodium polystyrene sulfonate 15000 MG Powder for Oral Suspension
RxCUI 2101899 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sodium polystyrene sulfonate
56512IN
-
Sodium polystyrene sulfonate
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sodium polystyrene sulfonate Powder for Oral Suspension
2101898SCDF -
Sodium polystyrene sulfonate Oral Powder Product
2101897SCDG -
Sodium polystyrene sulfonate Oral Product
1159945SCDG -
Powder for Oral Suspension
1540456DF -
Oral Powder Product
1294711DFG -
Oral Product
1151131DFG
-
Sodium polystyrene sulfonate Powder for Oral Suspension
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sodium polystyrene sulfonate 15000 MG
2101896SCDC
-
Sodium polystyrene sulfonate 15000 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sodium polystyrene sulfonate 15000 MG
SCDC · 2101896 -
Sodium polystyrene sulfonate Powder for Oral Suspension
SCDF · 2101898 -
Sodium polystyrene sulfonate Oral Powder Product
SCDG · 2101897 -
Sodium polystyrene sulfonate Oral Product
SCDG · 1159945
📦 FDA Products & Package NDCs
12 products · 20 package NDCs
20 package NDCs map to RxCUI 2101899 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 10702-0036-15 | 15 g in 1 BOTTLE (10702-036-15) | Sodium Polystyrene Sulfonate | KVK-Tech, Inc. | 2015-04-03 |
| 10702-0036-45 | 454 g in 1 JAR (10702-036-45) | Sodium Polystyrene Sulfonate | KVK-Tech, Inc. | 2012-07-25 |
| 11534-0166-15 | 15 g in 1 BOTTLE (11534-166-15) | SODIUM POLYSTYRENE SULFONATE | SUNRISE PHARMACEUTICAL, INC. | 2017-01-24 |
| 11534-0166-16 | 15 g in 1 BOTTLE (11534-166-16) | SODIUM POLYSTYRENE SULFONATE | SUNRISE PHARMACEUTICAL, INC. | 2017-01-24 |
| 11534-0166-44 | 454 g in 1 JAR (11534-166-44) | SODIUM POLYSTYRENE SULFONATE | SUNRISE PHARMACEUTICAL, INC. | 2017-01-24 |
| 17856-0024-01 | 50 CUP in 1 BOX, UNIT-DOSE (17856-0024-1) / 15 g in 1 CUP | Sodium Polystyrene Sulfonate | ATLANTIC BIOLOGICALS CORP. | 2023-04-11 |
| 17856-0024-02 | 50 CUP in 1 BOX, UNIT-DOSE (17856-0024-2) / 30 g in 1 CUP | Sodium Polystyrene Sulfonate | ATLANTIC BIOLOGICALS CORP. | 2023-04-11 |
| 24658-0760-16 | 453.6 g in 1 JAR (24658-760-16) | Sodium Polystyrene Sulfonate | PuraCap Laboratories, LLC | 2016-12-15 |
| 42806-0013-94 | 15 g in 1 BOTTLE (42806-013-94) | Sodium Polystyrene Sulfonate | Epic Pharma, LLC | 2022-09-15 |
| 42806-0013-96 | 453.6 g in 1 JAR (42806-013-96) | Sodium Polystyrene Sulfonate | Epic Pharma, LLC | 2014-04-14 |
| 46287-0012-16 | 454 g in 1 JAR (46287-012-16) | Sodium Polystyrene Sulfonate | CMP Pharma, Inc. | 1989-01-19 |
| 62135-0340-11 | 10 BOTTLE in 1 BOX (62135-340-11) / 15 g in 1 BOTTLE | Sodium Polystyrene Sulfonate | Chartwell RX, LLC | 2022-07-20 |
| 62135-0340-53 | 453.6 g in 1 BOTTLE (62135-340-53) | Sodium Polystyrene Sulfonate | Chartwell RX, LLC | 2022-07-20 |
| 62135-0340-62 | 15 g in 1 BOTTLE (62135-340-62) | Sodium Polystyrene Sulfonate | Chartwell RX, LLC | 2022-07-20 |
| 63629-2390-01 | 454 g in 1 JAR (63629-2390-1) | SODIUM POLYSTYRENE SULFONATE | Bryant Ranch Prepack | 2021-02-22 |
| 63629-8849-01 | 15 g in 1 BOTTLE (63629-8849-1) | SODIUM POLYSTYRENE SULFONATE | Bryant Ranch Prepack | 2021-09-20 |
| 63629-8850-01 | 15 g in 1 BOTTLE (63629-8850-1) | SODIUM POLYSTYRENE SULFONATE | Bryant Ranch Prepack | 2021-09-20 |
| 71335-2855-01 | 15 g in 1 BOTTLE (71335-2855-1) | SODIUM POLYSTYRENE SULFONATE | Bryant Ranch Prepack | 2025-10-21 |
| 72162-1230-02 | 454 g in 1 JAR (72162-1230-2) | SODIUM POLYSTYRENE SULFONATE | Bryant Ranch Prepack | 2023-09-13 |
| 72162-1230-07 | 15 g in 1 BOTTLE (72162-1230-7) | SODIUM POLYSTYRENE SULFONATE | Bryant Ranch Prepack | 2023-09-13 |
Observed labelers:
Bryant Ranch Prepack (6) ·
Chartwell RX, LLC (3) ·
SUNRISE PHARMACEUTICAL, INC. (3) ·
ATLANTIC BIOLOGICALS CORP. (2) ·
Epic Pharma, LLC (2) ·
KVK-Tech, Inc. (2)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.